Citation: | ZHANG Tingting, MEI Yinliu, DONG Wanfa, WANG Jingxun, JIN Liang, WU Jie. Protective effect of staphylococcal nuclease on 2, 4, 6-trinitro-benzene sulfonic acid-induced colitis in mice[J]. Journal of China Pharmaceutical University, 2020, 51(2): 198-205. DOI: 10.11665/j.issn.1000-5048.20200211 |
[1] |
Tighe D,McNamara D.Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease[J].World J Gastroenterol,2017,23(3):414-425.
|
[2] |
Grayson PC,Kaplan MJ.At the Bench:neutrophil extracellular traps(NETs)highlight novel aspects of innate immune system involvement in autoimmune diseases[J].J Leukoc Biol,2016,99(2):253-264.
|
[3] |
Hahn J,Knopf J,Maueroder C,et al.Neutrophils and neutrophil extracellular traps orchestrate initiation and resolution of inflammation[J].Clin Exp Rheumatol,2016,34(4 Suppl 98):6-8.
|
[4] |
Leslie RD,Bradford C.Autoimmune diabetes:caught in a NET[J].Diabetes,2014,63(12):4018-4020.
|
[5] |
Bennike TB,Carlsen TG,Ellingsen T,et al.Neutrophil extracellular traps in ulcerative colitis:a proteome analysis of intestinal biopsies[J].Inflamm Bowel Dis,2015,21(9):2052-2067.
|
[6] |
Zhou G,Song Y,Yang W,et al.ASCA,ANCA,ALCA and many more:are they useful in the diagnosis of Inflammatory Bowel Disease?[J].Dig Dis,2016,34(1/2):90-97.
|
[7] |
Jarrot PA,Kaplanski G.Pathogenesis of ANCA-associated vasculitis:an update[J].Autoimmun Rev,2016,15(7):704-713.
|
[8] |
Sangaletti S,Tripodo C,Chiodoni C,et al.Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity[J].Blood,2012,120(15):3007-3018.
|
[9] |
Gao X,Hao S,Yan H,et al.Neutrophil extracellular traps contribute to the intestine damage in endotoxemic rats[J].J Surg Res,2015,195(1):211-218.
|
[10] |
Martinez Valle F,Balada E,Ordi-Ros J,et al.DNase 1 and systemic lupus erythematosus[J].Autoimmun Rev,2008,7(5):359-363.
|
[11] |
Hong L,Lang J,Dongmei HE,et al.Studies on preparation and properties of Staphylococcus nuclease[J].J China Pharm Univ(中国药科大学学报),2017,48(2):214-219.
|
[12] |
Bahey-El-Din M,Gahan CG,Griffin BT.Lactococcus lactis as a cell factory for delivery of therapeutic proteins[J].Curr Gene Ther,2010,10(1):34-45.
|
[13] |
Ma Y,Liu J,Hou J,et al.Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice[J].PLoS One,2014,9(8):e105701.
|
[14] |
Lang J, Wang X, Liu K, et al. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice[J].Appl Microbiol Biotechnol,2017,101(20):7653-7662.
|
[15] |
Danese S,Sans M,Spencer DM,et al.Angiogenesis blockade as a new therapeutic approach to experimental colitis[J].Gut,2007,56(6):855-862.
|
[16] |
Dieleman LA,Palmen MJ,Akol H,et al.Chronic experimental colitis induced by dextran sulphate sodium(DSS)is characterized by Th1 and Th2 cytokines[J].Clin Exp Immunol,1998,114(3):385-391.
|
[17] |
Derkacz A,Olczyk P,Komosinska-Vassev K.Diagnostic markers for nonspecific inflammatory bowel diseases[J].Dis Markers,2018,2018:7451946.
|
[18] |
Wirtz S,Popp V,Kindermann M,et al.Chemically induced mouse models of acute and chronic intestinal inflammation[J].Nat Protoc,2017,12(7):1295-1309.
|
[19] |
de Bruyn M,Arijs I,De Hertogh G,et al.Serum neutrophil gelatinase b-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate marker for mucosal healing in patients with Crohn′s disease[J].J Crohns Colitis,2015,9(12):1079-1087.
|
[20] |
Kato S,Ochiai M,Sakurada T,et al.Increased expression of long pentraxin PTX3 in inflammatory bowel diseases[J].Dig Dis Sci,2008,53(7):1910-1916.
|
[21] |
Lehmann T,Schallert K,Vilchez-Vargas R,et al.Metaproteomics of fecal samples of Crohn′s disease and ulcerative colitis[J].J Proteomics,2019,201:93-103.
|
[22] |
Li T,Wang C,Liu Y,et al.Neutrophil extracellular traps induce intestinal damage and thrombotic tendency in inflammatory bowel disease[J].J Crohns Colitis,2020,14(2):240-253.
|
[23] |
Chumanevich AA,Causey CP,Knuckley BA,et al.Suppression of colitis in mice by Cl-amidine:a novel peptidylarginine deiminase inhibitor[J].Am J Physiol Gastrointest Liver Physiol,2011,300(6):G929-938.
|
[1] | YAO Lei, QU Linlin, FAN Daidi. Effects of rare ginsenoside on idiopathic pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2023, 54(5): 607-613. DOI: 10.11665/j.issn.1000-5048.2023042002 |
[2] | QIAN Xiuhui, SUN Jing, FU San, TANG Xiaoyan, XU Xianghong, ZHANG Mian. Effect of intratracheal instillation of PM2.5 suspensionon pulmonary fibrosis in mice and the intervention of neotuberostemonine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 455-462. DOI: 10.11665/j.issn.1000-5048.20210408 |
[3] | LI Xiaoshi, WU Xunxun, ZHENG Zuguo, YANG Hua, LI Ping. Advances of long noncoding RNAs in myocardial fibrosis[J]. Journal of China Pharmaceutical University, 2020, 51(6): 646-654. DOI: 10.11665/j.issn.1000-5048.20200602 |
[4] | CAI Yanfei, WAN Aini, CHEN Yun, JIN Jian. Anti-liver fibrosis activities of the extracellular domain of transforming growth factor beta type II receptor fusion protein in vivo[J]. Journal of China Pharmaceutical University, 2019, 50(2): 246-252. DOI: 10.11665/j.issn.1000-5048.20190217 |
[5] | XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415 |
[6] | FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302 |
[7] | ZHAO Limeng, WANG Shuzhen. Therapeutic applications of small molecule kinase inhibitors in liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(2): 147-157. DOI: 10.11665/j.issn.1000-5048.20180203 |
[8] | XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112 |
[9] | DAI Li, ZHANG Lu, JI Hui, KONG Xiang-wen. Therapeutic effects of ZK14,a novel nitric oxide donating biphenyldicarboxylate derivative,on hepatic fibrosis in rats[J]. Journal of China Pharmaceutical University, 2009, 40(3): 254-257. |
[10] | Danshen Inhibiting Isoproterenol Induced Cardiac Hypertrophy and Fibrosis in Mice and its Mechanisms[J]. Journal of China Pharmaceutical University, 2003, (6): 84-87. |